Slide 3

PURPOSE1 National Stakeholders Meeting, 17th September 2024

Slide 3

9th-10th Sept 2024 Inaugural SMILE-TB Protocol Training

Slide 3

5th-6th Sept 2024 PREPARE Consortium Meeting

Slide 3
Slide 3

MUJHU and BBS Terefayina MoU Signing

Slide 3

Outdoor play area facelift

Slide 3

SNIP Africa Stakeholder meeting with Midwives, Nurses and VHTs

Slide 3
Slide 3

2024 MOU signing with TASO

Slide 3
Slide 3
Slide 3

Part of the SMILE-TB Study team at MU-JHU

Slide 3
Slide 3
Slide 1
Slide 1
Slide 1
Slide 1
Slide 1
Slide 1
Slide 2
Slide 2
Slide 2
Slide 2
Slide 3
Slide 3
Slide 3
Slide 3
Slide 3
Slide 3
Slide 3
Slide 3
Slide 3
Slide 3
previous arrow
next arrow

Press

Podcasts

PXPulse Podcast
19th September 2024
This podcast episode, AVAC (AIDS Vaccine Advocacy Coalition)  takes a deep dive into the twice-yearly injectable LEN for PrEP to share the science, what made PURPOSE 1 a success, and what’s next to ensure effective and equitable delivery of this groundbreaking prevention product.

This episode features perspective from Principal Investigator, Dr. Flavia Kiweewa of Makerere University – Johns Hopkins University (MU-JHU), Chilufya Kasanda Hampongo of Zambia’s Treatment Advocacy and Literacy Campaign (TALC), and AVAC’s Executive Director, Mitchell Warren.

#LEN  #PrEP results

https://www.mujhu.org/wp-content/uploads/2024/09/GX13i82XcAAwvx2-2-e1726755700994.jpeg

Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention

Press Release | Foster City, Calif. – June 20, 2024- Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company’s twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, demonstrated 100% efficacy for the investigational use of HIV prevention in cisgender women.

Announcements

Grant Awards

2024-2025 HPTN Scholars Program

2024 International

Dr. Rita Nakalega

2024 IMPAACT
Early Career Investigators Award program

Dr. Patience Atuhaire

2023-2024 HPTN Scholar
Award

 

Dr. Phionah K. Ssemambo

2023 IMPAACT Early Career Investigator Award

 

Brenda Kakayi

2023-2025 James Hakim International HIV Investigator Mentoring Program (IHIMP) Award

Dr. Ronnie Kasirye

New Articles

Our Work

https://www.mujhu.org/wp-content/uploads/2022/03/01-research.png
https://www.mujhu.org/wp-content/uploads/2022/03/Programs.png
https://www.mujhu.org/wp-content/uploads/2022/03/03-Capacity-building.png
https://www.mujhu.org/wp-content/uploads/2023/03/Group-52.png
https://www.mujhu.org/wp-content/uploads/2022/03/05-corporate-social-responsibility.png

Latest Stories

Featured News

Fact Sheet | Gilead Sciences’ Lenacapavir and PURPOSE Program

17th September 2024
Read More
Featured News

High Level Stakeholder meeting for the Maternal Immunisation Platform Readiness Uganda

4th September 2024
Read More
Featured News

MU-JHU and BBS Terefayina Sign MoU

28th August 2024
Read More
Featured News

DROP-D Study Community Engagement Meeting at Kitebi Health Centre III

22nd August 2024
Read More
Featured News

Community Engagement Meeting for the SMILE-TB Study

16th August 2024
Read More
Featured News

MU-JHU at the AIDS2024 Conference in Germany

22-26 July, 2024
Read More
Events Featured

MU-JHU at the International Workshop on HIV & Pediatrics 2024

19-20 July 2024
Read More
Featured News

SNIP Africa Stakeholder Meeting for Midwives, Nurses and VHTs

24th July 2024
Read More
Featured News

MU-JHU at the 64th Society for Birth Defects Research and Prevention Annual Meeting

22-26 June 2024
Read More
Featured News

MU-JHU attends the 2024 HPTN Annual Network Meeting

20th June 2024
Read More
Featured News

MU-JHU Disseminates findings at INTEREST 2024

14th- 17th May in Cotonou, Benin
Read More
Featured News

Pictorial | Kabaka Birthday Run 2024

Read More
Featured News Staff Spotlight

January 2024 Graduation News

Read More
Featured News Press Releases

Press Release| Two New African-European Research Collaborations Tackle Severe Infections in Neonates and Children

Read More

Our Partners